Chemicals and pharmaceuticals · DVAX

DYNAVAX TECHNOLOGIES CORP

12 filings mentioning 11 of the compliance and risk topics we track. Every row links to the filing on EDGAR.

12filings we hold
11topics disclosed
Chemicals and pharmaceuticalsindustry
CAbased in

Across 12 filings we hold, DYNAVAX TECHNOLOGIES CORP has written down 11 of the topics we track. That places it 376 of 737 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

DVAX Chemicals and pharmaceuticals

What this obligates

Every instrument in our corpus that governs something DYNAVAX TECHNOLOGIES CORP has written into a filing. Not what they said. What applies once they have said it.

NIST Cybersecurity Framework 2.078
ISO/IEC 42001:202361
ISO 27001:202242
NIST AI Risk Management Framework (AI RMF 1.0)41
ISO 37001:201639
SOC 238
ASD Strategies to Mitigate Cyber Security Incidents29
GDPR26
ISO 3700126
AICPA Privacy Management Framework (PMF)22

10 frameworks, 402 controls between them, deduplicated across topics.

What it discloses

Tracked topics appearing in this company's filings, most frequent first.

Ransomware15
Cross Border Data Transfer12
Restatement9
Internal Control3
Material Weakness3
SOC 22
Consent Order2
Enforcement Action2
Vendor Risk Management1
Artificial Intelligence1
Data Breach1

Bars are scaled against this company's most frequent topic, not against the market. The table below has the exact counts.

TopicFilingsMost recent
Ransomware152025-12-29
Cross Border Data Transfer122025-11-05
Restatement92025-06-17
Internal Control32025-12-29
Material Weakness32025-12-29
SOC 222025-02-20
Consent Order22025-03-13
Enforcement Action22025-12-29
Vendor Risk Management12025-02-20
Artificial Intelligence12025-12-29
Data Breach12025-12-29

When it filed

Filings we hold, by year. Hover a bar for the count.

19
20
21
22
23
24
25

Recent filings

FiledFormItem
2025-12-298-KEntry into a material agreement, Director or officer departure, Regulation FD disclosurefiling
2025-11-0510-Qfiling
2025-08-0710-Qfiling
2025-06-178-KItem 3.03, Item 5.03, Shareholder votefiling
2025-05-0610-Qfiling
2025-03-138-KEntry into a material agreement, Item 2.03, Item 3.02filing
2025-02-2010-Kfiling
2024-11-0710-Qfiling
2024-08-0610-Qfiling
2024-05-248-KDirector or officer departure, Shareholder votefiling
2024-05-0810-Qfiling
2024-02-2210-Kfiling

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry. Each opens side by side with this one.

CompanyFilings
OPKOPKO HEALTH, INC.12compare →
FGENFIBROGEN INC12compare →
PTNPALATIN TECHNOLOGIES INC12compare →
OTLCOncotelic Therapeutics, Inc.12compare →
NKTRNEKTAR THERAPEUTICS12compare →
APALEXION PHARMACEUTICALS, INC.12compare →
New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition